AstraZeneca's clot-fighter Brilinta shows promise in diabetics with heart disease in big study - Endpoints News

AstraZeneca's clot-fighter Brilinta shows promise in diabetics with heart disease in big study  Endpoints News

As Pascal Soriot polishes the rough edges of his R&D shop within AstraZeneca, the British drugmaker reported some encouraging news that could help it ...